The long journey of individualizing antiplatelet therapy after acute coronary syndromes

Eur Heart J. 2020 Oct 1;41(37):3546-3548. doi: 10.1093/eurheartj/ehaa644.

Author

Robert F Storey^{1

2}

Affiliations

¹ Cardiovascular Research Unit, Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
² South Yorkshire Cardiothoracic Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

PMID: 33085968
DOI: 10.1093/eurheartj/ehaa644

No abstract available

Publication types

Editorial
Comment

MeSH terms

Acute Coronary Syndrome* / drug therapy
Aspirin / therapeutic use
Humans
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors / therapeutic use
Ticagrelor

Substances

Platelet Aggregation Inhibitors
Ticagrelor
Aspirin